Thomas P. Cirrito
Chief Executive Officer presso Y2x Life Sciences, LLC
Profilo
Thomas P.
Cirrito is the founder who has founded four companies.
He founded Filament BioSolutions, Inc. in 2013 and serves as Chairman & Chief Executive Officer.
He also founded Immunovent LLC in 2013 and serves as Chief Executive Officer.
In 2015, he founded Biotagenics, Inc. and serves as Chief Executive Officer.
In 2020, he founded Y2x Life Sciences, LLC and serves as Chief Executive Officer.
Dr. Cirrito also held former positions as Chief Executive Officer of Agelity Biomechanics, Inc. from 2014 to 2018, Operations Director of Stemline Therapeutics, Inc. in 2009, and Director of Antegrin Therapeutics LLC and Indalo Therapeutics, Inc. He also served as Independent Director of IN8bio, Inc. from 2016 to 2021.
Dr. Cirrito received his undergraduate and doctorate degrees from Washington University in St. Louis.
Posizioni attive di Thomas P. Cirrito
Società | Posizione | Inizio |
---|---|---|
Y2x Life Sciences, LLC | Chief Executive Officer | 01/02/2020 |
Biotagenics, Inc.
Biotagenics, Inc. BiotechnologyHealth Technology Biotagenics, Inc. develops novel therapeutics and diagnostics. The company is based in Toronto, Canada. The Canadian company was founded by Thomas P. Cirrito, Ali Riazi, Daniel Figeys, Alain Stintzi. Thomas P. Cirrito has been the CEO since incorporation. | Chief Executive Officer | 01/05/2015 |
Filament BioSolutions, Inc.
Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Filament BioSolutions, Inc. develops medical and functional foods for diseases. The company is based in Long Island City, NY. The company was founded by Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Chief Executive Officer | 01/01/2013 |
Immunovent LLC
Immunovent LLC Medical/Nursing ServicesHealth Services Immunovent LLC is a biotech company based in New York, NY. Immunovent is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented lamb-dx test. The lamb-dx test detects small amounts of antigen-specific ige from symptomatic areas of the body, such as the mouth and the nose, through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay. This allows for the rapid and safe diagnosis of common allergies without the inconveniences and issues of conventional skin prick and blood testing. The private company was founded by Kate Rochlin and Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Chief Executive Officer | 01/01/2013 |
Precedenti posizioni note di Thomas P. Cirrito
Società | Posizione | Fine |
---|---|---|
IN8BIO, INC. | Director/Board Member | 01/01/2021 |
Agelity Biomechanics, Inc.
Agelity Biomechanics, Inc. Medical SpecialtiesHealth Technology Agelity Biomechanics, Inc. is a private company based in New York that specializes in developing innovative technologies to improve human movement and mobility. Agelity Biomechanics is committed to advancing the field of biomechanics and helping people move better and live healthier lives. The American company was founded by Russell F. Warren and Suzanne Maher, and Dennis W. O'Dowd has been the CEO of the company since 2018. | Chief Executive Officer | 01/05/2018 |
Antegrin Therapeutics LLC
Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Antegrin Therapeutics LLC develops novel therapies for fibrotic diseases. It focuses on idiopathic pulmonary fibrotic diseases, which are conditions that involve out-of-control scarring of organs. The company was founded by David Griggs and Peter Ruminski in 2012 and is headquartered in St. Louis, MO. | Director/Board Member | - |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Director/Board Member | - |
STEMLINE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Thomas P. Cirrito
Washington University in St. Louis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
IN8BIO, INC. | Health Technology |
Aziende private | 8 |
---|---|
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
Antegrin Therapeutics LLC
Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Antegrin Therapeutics LLC develops novel therapies for fibrotic diseases. It focuses on idiopathic pulmonary fibrotic diseases, which are conditions that involve out-of-control scarring of organs. The company was founded by David Griggs and Peter Ruminski in 2012 and is headquartered in St. Louis, MO. | Health Technology |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Health Technology |
Filament BioSolutions, Inc.
Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Filament BioSolutions, Inc. develops medical and functional foods for diseases. The company is based in Long Island City, NY. The company was founded by Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Health Technology |
Immunovent LLC
Immunovent LLC Medical/Nursing ServicesHealth Services Immunovent LLC is a biotech company based in New York, NY. Immunovent is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented lamb-dx test. The lamb-dx test detects small amounts of antigen-specific ige from symptomatic areas of the body, such as the mouth and the nose, through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay. This allows for the rapid and safe diagnosis of common allergies without the inconveniences and issues of conventional skin prick and blood testing. The private company was founded by Kate Rochlin and Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Health Services |
Y2x Life Sciences, LLC | |
Biotagenics, Inc.
Biotagenics, Inc. BiotechnologyHealth Technology Biotagenics, Inc. develops novel therapeutics and diagnostics. The company is based in Toronto, Canada. The Canadian company was founded by Thomas P. Cirrito, Ali Riazi, Daniel Figeys, Alain Stintzi. Thomas P. Cirrito has been the CEO since incorporation. | Health Technology |
Agelity Biomechanics, Inc.
Agelity Biomechanics, Inc. Medical SpecialtiesHealth Technology Agelity Biomechanics, Inc. is a private company based in New York that specializes in developing innovative technologies to improve human movement and mobility. Agelity Biomechanics is committed to advancing the field of biomechanics and helping people move better and live healthier lives. The American company was founded by Russell F. Warren and Suzanne Maher, and Dennis W. O'Dowd has been the CEO of the company since 2018. | Health Technology |
- Borsa valori
- Insiders
- Thomas P. Cirrito